Aspen Pharmacare Hldgs (APNHF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. A very warm welcome to everyone joining us in person online for Aspen's 2025 interim results presentation. To kick things off, we'll hear from Stephen, our group CEO, who will take us and give us an overview of our performance. Following that, we'll have Sean, our group CFO, who will run us through the financial review. Stephen will then return to discuss our strategy, prospects, and guidance. And then finally, we'll open up the floor for questions and answers. For those joining us on the webcast, please feel free to type in your questions, and I'll be happy to read them out. We'll also be taking questions for those present in the room. With that, I'll now hand over to Stephen. Stephen, over to you. Good morning everyone and thank you for those that are here live and those that are online, welcome too. Interesting time and juncture that we've reached as Aspen. I'm trying to think, it might have been two or three presentations ago we gave you a presentation with green lines and red lines and the red with the headwinds and the green is where we hope to get to this point and financial year 25 was an important year for us. All the red lines came true. All the headwinds were there, and as is life, they all came true. But I'm also happy to tell you that our green lines, they also have come true. So where we stand today strategically, we have a commercial farmer business that has been de-risked, de-risked from a – let me see if we can get this thing going here, sorry – I'm trying to keep to the script, but I'm not very good at that, but de-risked from a perspective of we've dealt with China VBP, we've dealt with the issues within Russia, and so you're starting to see that base growth that we were talking about historically and without China in. And then we als...